课题基金 / 基金详情

DEVELOPMENT OF INFECTIOUS CLONES OF SIVSM STRAINS BELONGING TO DIFFERENT CLADES

DEVELOPMENT OF INFECTIOUS CLONES OF SIVSM STRAINS BELONGING TO DIFFERENT CLADES
属于不同进化枝的 SIVSM 菌株感染性克隆的开发
批准号:
7958637
负责人:
CRISTIAN APETREI
金额:
$5.99万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30

项目摘要

项目成果

CRISTIAN APETREI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Primary SIVsm isolates are significantly less pathogenic in Rh than the serially passaged SIVmac251/239. Our hypothesis is that the use of SIVsm strains representing different clades will generate a better model for AIDS pathogenesis. Our objective is to construct and characterize in vitro and in vivo infectious molecular clones of SIVsm strains belonging to different, well-defined phylogenetic lineages (clades). Total RNA from the sera of SIV infected animals M926, M946 (lineage 2), D215 (Lineage 6), FTQ (Lineage 5) and M923 (Lineage 1, recombinant strain) was isolated. Full length sequencing of these viruses is completed Other 10 new SIVsmm full length genomes has been generated. An infectious clone of SIVsmmM926 was obtained and is currently tested in vitro and in vivo. Remaining clone construction is in progress. An array of infectious molecular clones, which are better controlled by the immune system will provide enhanced and very much needed tools to the research community for AIDS immunopathogenesis and vaccine development investigating heterotypic protection in Rh.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of metabolic programing of T cells from the GI tract and related tissues on HIV reservoir seeding, maintenance and reactivation
New Strategy to Improve Gastrointestinal Health in SIV/HIV
Impact of a SARS-CoV-2 vaccine on gut integrity, immune activation and efficacy of ART
New Strategy to Improve Gastrointestinal Health in SIV/HIV
海外基金